HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SEER
Seer, Inc.
There isn't enough reported data to score SEER yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SEER Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Weak | |
| Unavailable |
SEER's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SEER PE Valuation
SEER has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SEER Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect SEER's losses to shrink, with revenue growing.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
SEER Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.15 | +$0.21 |
| Q2 2026 | -$1.22 | +$0.17 |
| Q1 2026 | -$1.24 | +$0.17 |
| Q4 2025 | -$1.28 | +$0.11 |
| Q3 2025 | -$1.36 | -$0.07 |
| Q2 2025 | -$1.39 | -$0.12 |
| Q1 2025 | -$1.41 | -$0.12 |
| Q4 2024 | -$1.39 | -$0.04 |
SEER is still losing money, but less than at its worst: $1.15 per share over the past year, against $1.49 at its worst in late 2022.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SEER on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SEER on profitability, with a higher operating margin.
SEER Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4M | +0.3% |
| Q2 2026 | $3.1M | -21% |
| Q1 2026 | $2.8M | -33% |
| Q4 2025 | $4.2M | +5% |
| Q3 2025 | $4M | -1.6% |
| Q2 2025 | $3.9M | +28% |
| Q1 2025 | $4.1M | +35% |
| Q4 2024 | $4M | -9.9% |
SEER's revenue is down over the past year, though its latest quarter was up: $4M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -368% | +119 points |
| Q2 2026 | -543% | -21 points |
| Q1 2026 | -618% | -118 points |
| Q4 2025 | -414% | +173 points |
| Q3 2025 | -487% | +116 points |
| Q2 2025 | -522% | +360 points |
| Q1 2025 | -500% | +322 points |
| Q4 2024 | -587% | -86 points |
SEER's operating margin was −368% last quarter, up 119 points from the same quarter a year ago, near the top of its range since 2019.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SEER on cash generation, producing positive trailing cash flow while its opponent burns cash.
SEER Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$10M | -$2.1M |
| Q2 2026 | -$9.6M | +$5.6M |
| Q1 2026 | -$15.7M | -$3.6M |
| Q4 2025 | -$11.1M | -$178K |
| Q3 2025 | -$7.8M | +$8.5M |
| Q2 2025 | -$15.2M | -$4M |
| Q1 2025 | -$12.1M | -$861K |
| Q4 2024 | -$10.9M | +$1.1M |
SEER has burned cash in almost every quarter: −$46M over the past year, against −$46M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SEER on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SEER Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +443K shares |
| 1 year | -0.9% | -498K shares |
| 3 years | -13% | -8.1M shares |
| 5 years | -8.7% | -5.3M shares |
| Available history | +58% | +20.4M shares |
SEER has 56M diluted shares, down 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2025 | $2M |
| Q2 2025 | $7.5M |
| Q1 2025 | $675,000 |
| Q4 2024 | — |
| Q3 2024 | $3.7M |
| Q4 2023 | — |
| Q3 2023 | $13,000 |
| Q2 2023 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SEER Net Leverage
SEER's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SEER Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 4.7 | Oversold |
SEER's weekly RSI is 39 (neutral) and its Stochastic is 5 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SEER PE vs Healthcare Sector
SEER has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SEER Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.91 | 17% below |
| 20 week MA | $1.97 | 19% below |
| 50 week MA | $1.88 | 15% below |
| 100 week MA | $2.00 | 20% below |
| 200 week MA | $2.32 | 31% below |
SEER is in a downtrend: it's below all five of its weekly moving averages, and 31% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SEER Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $56.5 | $62.0 | +9.9% |
| 2021 | $62.0 | $23.8 | -62% |
| 2022 | $23.8 | $5.65 | -76% |
| 2023 | $5.65 | $1.94 | -66% |
| 2024 | $1.94 | $2.26 | +16% |
| 2025 | $2.26 | $1.84 | -19% |
| 2026 YTD | $1.84 | $1.59 | -14% |
SEER has the edge over HIMS on returns for 2026, with the stronger performance.